Keith Klugman leads the Bill & Melinda Gates Foundation’s work to improve the development and delivery of pneumonia vaccines and expand the use of antibiotic treatments and diagnostic tools. Keith is a leading expert on antibiotic resistance in pneumonia pathogens and helped develop the pneumococcal vaccine that is part of the immunization regimen for children born in the US, which is also being rolled out globally. Previously, Keith served as a Professor of Global Health and Professor of Epidemiology in the Rollins School of Public Health at Emory University and Professor of Medicine in the Division of Infectious Diseases at the Emory School of Medicine. He serves as Honorary Professor in the Respiratory and Meningeal Pathogens Research Unit at the University of the Witwatersrand in South Africa.
Keith is currently the Past President of the International Society of Infectious Diseases; he is Treasurer of the Board of the International Symposium of Pneumococci and Pneumococcal Diseases; and a past Chair of the International Board of the American Society for Microbiology. In 2015, Keith was elected to membership of the US National Academy of Medicine. He has chaired or served on numerous expert committees for the World Health Organization (WHO), the Wellcome Trust and the Centers for Disease Control and Prevention (CDC). He serves as an editor or member of the editorial board of 16 journals.